Anxiety News and Research

Latest Anxiety News and Research

Elan and Transition Therapeutics report results of ELND005 Phase 2 study for Alzheimer's disease

Elan Corporation, plc and Transition Therapeutics, Inc today announced the results of a Phase 2 placebo-controlled study in 351 patients with mild to moderate Alzheimer's disease who received study drug for up to 18 months (Study AD201). Study subjects with MMSE scores between 16 and 26 received ELND005 oral doses of 250 mg, 1000 mg or 2000 mg twice daily or matching placebo. The study's cognitive (NTB) and functional (ADCS-ADL) co - primary endpoints did not achieve statistical significance.

10 Aug 2010

Study finds selective serotonin reuptake inhibitors not beneficial for autistic children

Antidepressants commonly prescribed to people with autistic spectrum disorders cannot be recommended based on current evidence, a new study by Cochrane Researchers concludes. Despite some evidence of benefits in adults diagnosed with autism, they say there is no evidence for any benefits associated with selective serotonin reuptake inhibitors (SSRIs) in children, who may suffer serious adverse effects as a result of taking the drugs.

9 Aug 2010

Antidepressants cannot be recommended in children with autism: Study

According to a thorough review published by Cochrane Researchers, commonly prescribed antidepressant drugs cannot be recommended for those suffering from autistic spectrum disorders based on current evidence. They say that there may be benefits of antidepressants in adults diagnosed with autism but similar benefits are not seen in children. These children may suffer extremely adverse effects if they consume selective serotonin reuptake inhibitors (SSRIs).

8 Aug 2010

Asynchronous telepsychiatry provides primary-care physicians greater access to psychiatric consultation

A new study by researchers at the UC Davis School of Medicine has found that psychiatrists can accurately assess a patient's mental health by viewing videotaped interviews that are sent to them for consultation and treatment recommendations.

7 Aug 2010

Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study

A newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana, but that is produced by the body's own nerve cells.

7 Aug 2010

Vyvanse Capsules CII demonstrates significant improvement in adults with ADHD: Phase 3b study

Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.

6 Aug 2010

TEMPO study recommends early administration of Azilect in PD patients

Teva Pharmaceutical Industries Ltd. and H. Lundbeck A/S (Lundbeck) today announced newly published long-term data on Azilect(rasagiline tablets) from the TEMPO study and its open-label extension. The findings confirm the long-term efficacy, safety and tolerability of Azilect® in patients with Parkinson's disease (PD) and further demonstrate the benefits obtained with early treatment initiation. The data was published in the June 2010 issue of the International Journal of Neuroscience.

6 Aug 2010

House to return after Senate approves extension of enhanced Medicaid funds

House Speaker Nancy Pelosi will bring the House back from its recess next week to vote on an extension of enhanced state Medicaid funds the Senate is poised to approve as soon as Thursday afternoon, Politico reports.

6 Aug 2010

Free clinic in D.C. draws more than 1,000 patients

With a wounded economy and high unemployment, more than 1,000 people came to a one-day free health clinic in the nation's capital Wednesday to get the basic care they can't afford or are otherwise denied because they have no insurance. More than three-quarters of those attending don't have insurance because they are recently unemployed, work for small businesses, earn hourly wages, or must work multiple part-time jobs with no insurance, said the event's medical director Dr. Bobby Kapur.

6 Aug 2010

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been completed and met the primary endpoints: in both studies in patients with chronic hepatitis C virus (HCV) genotype 1 infection, the addition of boceprevir to treatment with PEGINTRON® and REBETOL® significantly increased the number of patients who achieved sustained virologic response, compared to control groups that received Peg/riba plus placebo.

5 Aug 2010

Healing Touch helps to restore normal energy balance

Greenwich Hospital surgical, labor and delivery, and oncology patients are among those who have received a healing boost through a form of energy therapy known as Healing Touch.The hospital, known for its reputation of service excellence, is among a growing number of medical facilities utilizing Healing Touch, which is a gentle, noninvasive therapy shown to facilitate the relaxation response to enhance the healing process. Research shows that, in addition to inducing a deep sense of calm and relaxation, Healing Touch helps to reduce pain, decrease anxiety, promote sleep and improve an overall sense of well-being.

5 Aug 2010

University of Pennsylvania announces recipients of 2010 Templeton Positive Neuroscience Awards

The Positive Psychology Center of the University of Pennsylvania and the John Templeton Foundation have announced the recipients of the 2010 Templeton Positive Neuroscience Awards, $2.9 million given to 15 new research projects at the intersection of neuroscience and positive psychology.

5 Aug 2010

Mothers of premature babies have high levels of stress and anxiety

The incidence of premature babies has been stable or even increased over time. The phenomenon brings with it the possibility of neurological, sensorial, respiratory, cognitive or psychomotor consequences for the child, both in the short and the medium term. These consequences also are a concern to child psychiatrists and psychologists, as it is currently known that the progress of a premature baby and the appearance or otherwise of problems depend largely on the family environment, above all how the mother interacts with her child in the first months of its life.

5 Aug 2010

HGC publishes guidelines to protect people using DIY genetic tests

A set of guidelines has been published to protect people using DIY genetic tests for inherited diseases, such as certain types of breast cancer.The guidelines have been drawn up by the Human Genetics Commission (HGC), which hopes to provide the public with greater confidence in genetic testing kits.Companies - many of which are based in the US - have started to sell DIY testing kits over the internet, providing users with an estimate of their risk of inheriting diseases.

5 Aug 2010

Thinking of God reduces distress to anxiety-provoking mistakes: Study

Thinking about God may make you less upset about making errors, according to a new study published in Psychological Science, a journal of the Association for Psychological Science. The researchers measured brain waves for a particular kind of distress-response while participants made mistakes on a test. Those who had been prepared with religious thoughts had a less prominent response to mistakes than those who hadn't.

5 Aug 2010

Research examines effects of orthostatic hypotension in adults, children

A simple variation to the tried and true method of checking blood pressure can reveal startling information about both older and younger persons, new research suggests.

4 Aug 2010

Report examines effects of traumatic events on mental health status of adults in Central African Republic

More than three-quarters of adults in the Central African Republic report witnessing or personally experiencing traumatic events during the most recent wave of violence, and more than half meet criteria for depression or anxiety, according to a report in the August 4 issue of JAMA, a theme issue on violence and human rights.

4 Aug 2010

Invivo recognized with 2010 Gold Medical Design Excellence Award

On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.

4 Aug 2010

DTB launches Don't Drop Mixtard 30 campaign to change Novo Nordisk's drug removal decision

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add 9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin (DTB). The decision could also leave thousands of patients dependent on others to help them take their insulin, says DTB, which today launches its "Don't Drop Mixtard 30" campaign to convince the company to change its mind.

4 Aug 2010

Lack of understanding about anesthesia may lead patients to postpone surgery

Lack of understanding and apprehension about anesthesia may lead as many as one in four patients to postpone surgery according to the Vital Health Report, a quarterly health survey of Americans released today by the American Society of Anesthesiologists (ASA).

4 Aug 2010

Anxiety News and Research

Latest Anxiety News and Research

Elan and Transition Therapeutics report results of ELND005 Phase 2 study for Alzheimer's disease

Study finds selective serotonin reuptake inhibitors not beneficial for autistic children

Antidepressants cannot be recommended in children with autism: Study

Asynchronous telepsychiatry provides primary-care physicians greater access to psychiatric consultation

Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study

Vyvanse Capsules CII demonstrates significant improvement in adults with ADHD: Phase 3b study

TEMPO study recommends early administration of Azilect in PD patients

House to return after Senate approves extension of enhanced Medicaid funds

Free clinic in D.C. draws more than 1,000 patients

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Healing Touch helps to restore normal energy balance

University of Pennsylvania announces recipients of 2010 Templeton Positive Neuroscience Awards

Mothers of premature babies have high levels of stress and anxiety

HGC publishes guidelines to protect people using DIY genetic tests

Thinking of God reduces distress to anxiety-provoking mistakes: Study

Research examines effects of orthostatic hypotension in adults, children

Report examines effects of traumatic events on mental health status of adults in Central African Republic

Invivo recognized with 2010 Gold Medical Design Excellence Award

DTB launches Don't Drop Mixtard 30 campaign to change Novo Nordisk's drug removal decision

Lack of understanding about anesthesia may lead patients to postpone surgery

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Anxiety News and Research

Latest Anxiety News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in